Skip to content
Screener

Coya Therapeutics, Inc. COYA Q2 2026 earnings

Reported August 11, 2026 · Before market open

Revenue$221.9KBeat by $91.9K
EPS-$0.28Beat by $0.07
Revenue estimate$130.0K
EPS estimate-$0.35

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$110.0K
EPS estimate-$0.35

FAQ

When did Coya Therapeutics, Inc. report Q2 2026 earnings?
Coya Therapeutics, Inc. (COYA) reported Q2 2026 earnings on August 11, 2026 before market open.
What were Coya Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Coya Therapeutics, Inc. reported revenue of $221.9K and eps of $-0.28 for Q2 2026.
Did Coya Therapeutics, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $130.0K by $91.9K. EPS beat the consensus estimate of $-0.35 by $0.07.
How did Coya Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 35.6% from $163.6K a year earlier and eps grew 22.2% from $-0.36.
Where can I find Coya Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-343473) and the 10-Q periodic report (0001193125-26-343481) directly on SEC EDGAR. The filing index links above go to sec.gov.